Medtronic’s top ventilator executive began fielding pleas from world leaders' representatives five years ago, as pressure ...
The U.S. Food and Drug Administration on Tuesday classified the recall of Medtronic's embolization device as "most serious", ...
Wall Street's major averages closed in the green on Friday, and the benchmark S&P 500 (SP500) snapped a four-week losing streak after U.S. President Donald Trump said there might be some "flexibility" ...
Evolut showed less bioprosthetic valve dysfunction, prosthetic valve thrombosis and haemodynamic structural valve dysfunction ...
Medtronic reported 4.1% organic revenue growth and 6.2% adjusted EPS growth. See why we upgraded MDT stock to 'Buy' with a ...
Medtronic will remove one model of Pipeline Vantage devices from where they’re used and sold and will update the instructions ...
3d
Zacks.com on MSNMedtronic (MDT) Up 5.6% Since Last Earnings Report: Can It Continue?Medtronic (MDT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
The FDA recall affects more than 25,000 of the Fridley-run company’s devices and follows reports of 17 injuries.
The recall, which affects two models of Pipeline Vantage embolization devices, is linked to 17 injuries and four deaths.
Medtronic has recalled certain Pipeline Vantage Embolization Devices with Shield Technology due to an increased risk of ...
Medtronic (NYSE:MDT) today announced real-world data supporting the use of its smart insulin pen and CGM sensor combination.
Medtronic’s top ventilator executive began fielding pleas from world leaders’ representatives five years ago, as pressure from a global pandemic drove a sudden shortage of lifesaving devices ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results